Dual binding site acetylcholinesterase inhibitors for the treatment of Alzheimer's disease

Details for Australian Patent Application No. 2003269240 (hide)

International Classifications

Event Publications

15 January 2004 Complete Application Filed

Priority application(s): 0223494.6 09.10.02 GB

3 June 2004 Application Open to Public Inspection

Published as AU-B-2003269240

30 June 2005 Amendment Made

The nature of the amendment is: Amend the name of the applicant/patentee from NeuroPharma, S.A. to Neuropharma, S.A.

28 January 2010 Alteration of Name

The name of the applicant has been altered to Noscira, S.A.

18 February 2010 Application Accepted

Published as AU-B-2003269240

17 June 2010 Standard Patent Sealed

3 May 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.